image
Healthcare - Biotechnology - NASDAQ - US
$ 4.21
-1.41 %
$ 251 M
Market Cap
-5.61
P/E
BALANCE SHEET
148 M ASSETS
-18.18%
28.5 M LIABILITIES
-5.78%
120 M EQUITY
-20.67%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Aldeyra Therapeutics, Inc.
image
Current Assets 143 M
Cash & Short-Term Investments 143 M
Receivables 0
Other Current Assets 524 K
Non-Current Assets 517 K
Long-Term Investments 0
PP&E 517 K
Other Non-Current Assets 0
Current Liabilities 22.3 M
Accounts Payable 1.34 M
Short-Term Debt 15.6 M
Other Current Liabilities 5.3 M
Non-Current Liabilities 6.27 M
Long-Term Debt 543 K
Other Non-Current Liabilities 5.73 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 142.8 144.4 229.8 77.9 44.4 47.4 20.0 12.0 14.6 8.5 3.3 1.2 0.3
Short Term Investments 0 29.9 0 0 28.9 46.2 22.9 12.9 12.9 0 0 0 0
Receivables 0 3.2 125.0 0 0 0 0 0 0 0 0 0.8 0
Inventory 0 (3.2) (125.0) (20.2) (28.0) 0 0 0 0 0 0 0 0
Other Current Assets 0.5 7.2 2.9 5.2 1.8 1.2 1.0 0.4 1.0 0.5 16.8 K 2.95 K 4.21 K
Total Current Assets 143.3 181.0 232.8 83.1 75.2 94.8 44.0 25.1 28.1 8.8 3.3 2.0 0.3
PP&E 0.5 0.3 0.4 0.3 0.3 0.2 43.3 K 56.4 K 80.3 K 13 K 0 0 3.74 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 0 96.1 K 63.7 K 54.9 K 86.6 K 0.2 0 36.2 K 14.2 K 0.5 0 0
Other Assets 4.5 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 148.3 181.3 233.1 83.4 75.5 95.1 44.2 25.2 28.2 8.8 3.7 2.0 0.3
LIABILITIES
Accounts Payable 1.3 0.1 1.0 0.4 0.8 3.1 1.0 0.3 0.9 0.3 0.3 72.5 K 25.3 K
Short Term Debt 15.6 1.4 0.2 3.9 0.2 0 0.1 77.5 K 77.5 K 77.5 K 0.1 0.2 2.2
Other Current Liabilities 5.3 13.8 10.5 8.1 11.9 5.4 2.2 1.9 1.2 0.9 0.1 0.1 0.4
Total Current Liabilities 22.3 15.4 11.8 12.4 12.9 8.5 3.4 2.3 2.1 1.3 0.6 0.4 2.6
Long Term Debt 0.5 14.9 15 628 935.1 11.4 14.5 0 1.2 1.2 1.2 1.2 1.1 0.3 0
Deferred Tax Income 0 0 96.1 K 63.7 K 54.9 K 0 0 0 0 0 0 0 0
Other Liabilities (0.3) 0 (15 628 919.5) 0 0 0 0 0 0 0 0.4 26.5 0
Total Liabilities 28.5 30.3 27.4 23.8 27.4 8.5 4.6 3.5 3.3 2.5 2.1 27.1 2.6
EQUITY
Common Stock 59.2 K 58.6 K 58.1 K 38.7 K 28.7 K 26.2 K 19.1 K 12.6 K 9.71 K 5.56 K 4.04 K 3.77 K 3.77 K
Retained Earnings (394.3) (356.7) (294.7) (236.9) (199.4) (138.5) (99.6) (77.3) (58.6) (46.5) (41.3) (54.4) (15.5)
Other Accumulative Comprehensive Income/Loss 0 (0.1) 0 0 5.87 K 9.22 K 17.8 K 129 8.36 K (8.8) (41.8) 0 0
Total Equity 119.8 151.0 205.7 59.5 48.1 86.6 39.6 21.6 24.9 6.3 1.6 (25.2) (2.3)
Total Liabilities and Equity 148.3 181.3 233.1 83.4 75.5 95.1 44.2 25.2 28.2 8.8 3.7 2.0 0.3
SHARES OUTSTANDING
Common Shares Outstanding 58.9 58.4 54.0 34.0 27.1 21.7 15.9 11.4 8.6 3.8 0.3 4.0 0.3